Using qualitative exit interviews to explore schizophrenia burden and treatment experience in clinical trial patients

Collection of qualitative information within a schizophrenia clinical development process provides value and insights into patients' views on burden of illness, experiences with previous medications, and experiences following participation in a clinical trial and can inform design for future studies.